Professor and Jack L. Beal Chair; Editor, Journal of Natural Products
Dr. A. Douglas Kinghorn has been Professor and Jack L. Beal Chair in Natural Products Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University since 2004. He received doctoral degrees from the University of London [Ph.D. in Pharmacognosy, 1975; D.Sc. in Pharmacy, 1990]. Dr. Kinghorn performed postdoctoral work at the University of Mississippi and the University of Illinois at Chicago. His research interests are on the isolation, characterization, and biological evaluation of natural products from higher plants, particularly with potential anticancer, anti-infective, and taste-modifying activities.
Dr. Kinghorn is a Fellow of five scientific and professional societies and of The School of Pharmacy, University College London (UCL). Dr. Kinghorn was designated as the 1993 B. Kenneth West University Scholar (Senior University Scholar) by the University of Illinois Foundation and was awarded the 2002-2003 University of Illinois at Chicago Award for Excellence in Teaching. He received the 2010 Norman R. Farnsworth Research Achievement Award of the American Society of Pharmacognosy for lifetime contributions to natural products research. In December 2011, he was awarded an Honorary Doctor of Science degree from the University of Bradford in the United Kingdom. He has authored or co-authored about 475 peer-reviewed research articles, review articles, and book chapters. Dr. Kinghorn has been Major and/or Thesis Advisor/Committee Member Chair to ca. 45 graduate students and has supervised over 60 postdoctorals and visiting scholars.
R&D Director, System Integration, Becton Dickinson and Company, Diagnostic Systems
Adam earned a B.S. in Mathematics and Chemistry from Gettysburg College and holds a Ph.D. in Analytical Chemistry from the University of Maryland, College Park. Adam was a National Science Foundation post-doctoral fellow at the National Institute of Standards and Technology in Gaithersburg, MD for two years. He then moved to industry as a Scientist with Gene Logic working in the field of DNA microarrays. Adam moved into technical management with MetriGenix, as a spin-out of Gene Logic, as the Director of Product Development and eventually the Vice President for Research and Development. In 2005, Adam joined Becton Dickinson and Company in the Diabetes Care business unit developing continuous glucose monitoring products. He transitioned to the Diagnostics Systems business unit in 2007 as the leader for System Engineering department which is his current role. Adam has been a member of the ACS since his undergraduate studies at Gettysburg College.
Adrian’s background in the pharmaceutical and agrochemical industries gives him an in-depth understanding of his clients’ business goals. This enables him to provide them with focused, commercially minded advice in the areas of patents, designs and supplementary protection certificates.
Adrian works closely with Fraser Brown, Nick Bennett and Hazel Stewart to advise clients, particularly in the life sciences. Adrian develops close and long standing relationships with domestic clients, multinational corporations and overseas attorneys, who like his direct and collaborative approach.
Adrian has a particular expertise in post-grant issues in the pharmaceutical industry, which has been used to the particular advantage of clients based outside Europe, who rely on Adrian to help develop and implement their European strategies. Adrian also enjoys representing clients in oral proceedings at the EPO. Adrian Bradley – energising ideas for Cleveland clients since 2007
Editor-in-Chief, Organic Letters
Amos B. Smith, III, is the Rhodes-Thompson Professor of Chemistry as well as Member of the Monell Chemical Senses Center and Associate Director of the Penn Center for Molecular Discovery at the University of Pennsylvania. In addition, he is both an Honorary Member and Visiting Director of the Kitasato Institute in Tokyo. Dr. Smith's research is dedicated to natural product synthesis, bioorganic chemistry, and materials science. More than 75 architecturally complex natural products have been prepared in his laboratory. Moreover, Dr. Smith, in collaboration with Ralph Hirschmann, pioneered the design and synthesis of non-peptide peptidomimetics of neuropeptideic hormone/transmitters and protease enzyme inhibitors. In collaboration with Peter Jurs, Dr. Smith developed groundbreaking computerized pattern recognition techniques that make it possible to analyze primate chemical communication.
Dr. Smith received his PhD from Rockefeller University. To date, he has co-authored over 575 publications and delivered over 600 invited lectures, including plenary lectures at the National Organic Chemistry Symposium and numerous Gordon Research Conferences. His recent honors and awards include Honorary Membership in the Pharmaceutical Society of Japan, Fellow of the American Association for the Advancement of Science, Royal Society of Chemistry Centenary Medal, Yamada Prize, Fellow of the American Academy of the Arts and Sciences, and Inaugural Fellow of the American Chemical Society.Kolkata, India
Scientific Officer, Swiss Federal Office for the Environment (FOEN)
Andreas Buser received a master's degree in environmental sciences with a major in environmental chemistry at ETH Zurich in 2005 and a PhD on the topic “Siloxanes: Emissions, Properties and Environmental Fate” in 2013. Before rejoining ETH for his PhD thesis, he had worked as a consultant on substance flow analyses of persistent organic pollutants and biocides for three years. Since January 2014 he has been working as a scientific officer in the Industrial Chemicals Section of the Swiss Federal Office for the Environment. His major tasks include carrying out and reviewing hazard and risk assessments of chemicals on a national and an international level.
President, Director and Founder of Tait Laboratories Inc.
Dr. Tait is President, Director and Founder of Tait Laboratories Inc., a company that is devoted to modernizing traditional herbal medicines through science and technology. He received his B.Sc. and M.Sc. from Concordia University (Montreal) with a research focus on environmental enzymology. Afterwards, he moved to Vancouver to complete a Ph.D. in Chemistry at the University of British Columbia. During his thesis work on viral triggers of multiple sclerosis, he came across some Traditional Chinese Medicines that have potential to treat a wide range of chronic diseases; he then founded the company while finishing his graduate studies.
In 2012, he was invited to Ottawa to be awarded the NSERC Innovation Challenge Award, for successfully translating his research to an entrepreneurial venture. That same year, he also gave the keynote presentation on multiple sclerosis at the Boucher Institute of Naturopathic Medicine’s annual symposium.
Supported by the Canadian Youth Business Foundation, the Bank of Development of Canada, the University of British Columbia’s Entrepreneurship@UBC program, and the National Research Council Industry Research Assistance Program, he works closely with industrial and academic researchers to develop safe, affordable, natural and effective therapies for chronic diseases like MS. His current research interests focus on the intimate connection between neuroimmunology and the gastrointestinal tract.
Senior Associate Dean for Research and Graduate Education, Professor of Chemistry and Cooper Fellow in the College of Arts and Sciences, University of Miami
Angel E. Kaifer received his undergraduate education in Chemistry at Universidad Autónoma de Madrid, Spain. In 1979 he moved to Puerto Rico, where he taught for three years at Humacao University College and later pursued his graduate education at the University of Puerto Rico, Rio Piedras. After completing his PhD degree in 1984 he did postdoctoral work at the University of Texas, Austin. He joined the chemistry faculty of the University of Miami as an Assistant Professor in 1985.
His research work, continuously supported by the National Science Foundation since 1990, focuses on the redox modulation of molecular recognition events. More recently, his research interests have centered on the design, preparation and characterization of nanometer-sized systems, such as dendrimers, functionalized for electron transfer and molecular recognition reactions. A substantial fraction of his research activities deals with the binding properties of cucurbit[n]uril hosts. He has published more than 200 papers and book chapters on these research topics. In 1999 he authored the book Supramolecular Electrochemistry, which was the first published monograph on this research field. He has also served in the Editorial Board of Langmuir, Supramolecular Chemistry and the Journal of Supramolecular Chemistry, as well as in many NSF and NIH review panels. He was one of the Associate Editors for the Journal of Physical Organic Chemistry.
His research group has served as a training ground for numerous minority and female students. Out of 26 PhD graduates, eight are from Hispanic origin and ten are women, with three Hispanic women as the overlap between the two groups. In addition, four female students, two of them Hispanic, have obtained a MS degree. Many other underrepresented undergraduate and high school students have received research training in the Kaifer group.